The organizer's invitation

Dear Colleagues,

We are pleased to invite you to attend the 29th International Conference entitled "Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells" which will be held from the 25th to the 27th June 2012 at the Santa Marina Hotel, in Mykonos, Greece.

It will be followed by the 2nd International Conference "Notch Targeting in Cancer" which will take place at the same hotel from the 27th to the 29th June 2012.

This year's meetings promise to be exciting educational events where presentations, open air workshops and expert discussions.

You may wish to participate in one or the other conference or accept a special offer and participate in both events.

The 2012 meetings promise to be exciting educational events where presentations, open air workshops and expert discussions led by key opinion leaders in the field will provide the essence of the program content for all of us involved in laboratory research and clinical diagnosis and management of cancers using monoclonal antibodies as well as it explains the new and exciting field of Notch. By the conclusion of the meetings, attendees will be able to bring themselves up to date with research developments and to identify emerging therapies as well as to develop valuable strategies to integrate them into current disease management.

We are looking forward to welcoming you to beautiful Mykonos for what is sure to be a very rewarding experience.

Sincerely,

Prof. Agamemnon Epenetos
Conference Organizer

Back to top | Back

» Organizer's message
» Contact us
» The venue

Please access the hotel website, www.santa-marina.gr, to book mentioning your participation at the conference(s) in order to benefit of the special rates. Also, we would recommend the following other hotels if you do not wish to stay at the Santa Marina Resort:
» Hotel Yiannakis
» Dionysos Hotel
» Deliades Hotel
» Elenis Studio


THE 29TH CONFERENCE ON MONOCLONAL ANTIBODIES AND CANCER STEM CELLS.

THE 27TH CONFERENCE ON MONOCLONAL ANTIBODIES